VEAPSRandomized, double-blind, placebo-controlled, 3-year non-invasive arterial imaging primary prevention clinical trial to determine if vitamin E supplementation reduces the progression of atherosclerosis (carotid intima-media thickness) in healthy men and women 40 years and older.

Funding Sources

This study was supported by the National Institute on Aging and Hoffmann-La Roche, Inc.

Registered at under NCT00114387